Role of gastric acid in the aetiology of dyspeptic disease and dyspepsia

Bailliere's Clinical Gastroenterology

Volumn 12, Issue 3, 1998, Pages 489-502

  McColl, Kenneth E L ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

Duodenal ulcer; Dyspepsia; Gastric acid; Gastro oesophageal; Non ulcer dyspepsia; Reflux disease

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PENTAGASTRIN; PROTON PUMP INHIBITOR; RANITIDINE; STOMACH SECRETION INHIBITOR;

ARTICLE; DUODENUM ULCER; DYSPEPSIA; ESOPHAGITIS; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HUMAN; PATHOPHYSIOLOGY; PEPTIC ULCER; PRIORITY JOURNAL; REBOUND; STOMACH ACID; STOMACH ACID SECRETION; SYMPTOM;

EID: 0031763256     PISSN: 09503528     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3528(98)90020-3     Document Type: Article

References (63)

1. Bardhan KD, Saul DM, Edwards JL et al (1979) Comparison of two doses of cimetidine and placebo in the treatment of duodenal ulcer: a multicentre trial. Gut 20: 68-74.
2. Bates S, Per-Orlow S, Fellenius J & Nyrén O (1989) Blocked and non-blocked acid secretion and reported pain in ulcer, non-ulcer dyspepsia, and normal subjects. Gastroenterology 97: 376-383.
3. Bateson MC & Bouchier IAD (1981) The association of oesophagitis with disease in the stomach and duodenum. Postgraduate Medical Journal 57: 217-218.
4. Beales ILP & Calam J (1996) Helicobacter pylori infection and exogenous tumour necrosis factor alpha (TNFα) produce similar effects on gastrin release from human antral fragments. Gut 38 (supplement): A12.
5. Behar J, Biancani P & Sheahan DG (1976) Evaluation of esophageal tests in the diagnosis of reflux esophagitis. Gastroenterology 71: 9-15.
6. Blair AJ, Feldman M, Barnett C et al (1987) Detailed comparison of basal and food-stimulated gastric acid secretion rates and serum gastrin concentrations in duodenal ulcer patients and normal subjects. Journal of Clinical Investigation 79: 582-587.
7. Boesby S (1977a) Gastric acid secretion in patients with symptomatic hiatus hernia and effect of a modified Belsey MK IV repair on gastric acid secretion. Scandinavian Journal of Gastroenterology 12: 401-406.
8. Boesby S (1977b) Relationship between gastro-oesophageal acid reflux, basal gastro-oesophageal sphincter pressure and gastric acid secretion. Scandinavian Journal of Gastroenterology 12: 547-551.
9. Boyd EJS (1996) The prevalence of esophagitis in patients with duodenal ulcer of ulcer-like dyspepsia. American Journal of Gastroenterology 91(8): 1539-1542.
10. Cadiot G, Bruhat D, Coste T et al (1997) Multivariate analysis of pathophysiological factors in reflux oesophagitis. Gut 40: 167-174.
11. Collen MJ & Loebenberg MJ (1989) Basal gastric acid secretion in non-ulcer dyspepsia with or without duodenitis. Digestive Diseases and Sciences 34(2): 246-250.
12. Collen MJ, Lewis JH & Benjamin SB (1990) Gastric acid hypersecretion in refractory gastroesophageal reflux disease. Gastroenterology 98: 654-661.
13. Csendes A, Larrain A & Uribe P (1974) Gastric acid secretion in patients with a symptomatic gastroesophageal reflux and patients with esophageal strictures. Annals of Surgery 179: 119-122.
14. Dabrilla G, Camberlata M, Steele A & Vallaperta P (1989) Drug treatment of functional dyspepsia: a meta-analysis of randomised controlled trials. Journal of Clinical Gastroenterology 11: 169-177.
15. Earlam RJ (1972) Further experience with epigastric pain reproduction test in duodenal ulceration. British Medical Journal 2: 683-685.
16. El-Omar E, Penman I, Dorrian CA et al (1993) Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two-thirds in patients with duodenal ulcer. Gut 34: 1060-1065.
17. El-Omar E, Penman ID, Ardill JES et al (1995a) Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 109: 681-691.
18. El-Omar E, Penman I, Ardill JES & McColl KEL (1995b) A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients. Gut 36: 534-538.
19. El-Omar E, Banerjee S, Wirz A et al (1996) Marked rebound acid hypersecretion following treatment with ranitidine. American Journal of Gastroenterology 91: 385-389.
20. 2-antagonist withdrawal - a comparative study with nizatidine, ranitidine and famotidine. Alimentary Pharmacology and Therapeutics 5: 391-398.
21. 2 receptor antagonist. Gut 30(4): 449-454.
22. Gatzinsky P, Granerus G & Sandberg N (1980) Gastric acid secretion (GAS) and hiatal hernia. I. Relationship between GAS and oesophageal reflux complications. Acta Chirugica Scandinavica 146: 583-589.
23. George AA, Tsuchiyose M & Dooley CP (1991) Sensitivity of the gastric mucosa to acid and duodenal contents in patients with non-ulcer dyspepsia. Gastroenterology 101: 3-6.
24. Gilbert DA, Silverstien FE, Tedesco FJ et al (1981) The national ASGE survey on upper gastrointestinal bleeding. III. Endoscopy in upper gastrointestinal bleeding. Gastrointestinal Endoscopy 27: 94-102.
25. Gillen D, Wirz A & McColl KEL (1997) Marked rebound acid hypersecretion following omeprazole therapy in H. pylori negative subjects. Gastroenterology 112: A126.
26. Gillen D, El-Omar EM, Wirz AA et al (1998) The acid response to gastrin distinguishes duodenal ulcer patients from Helicobacter pylori-infected subjects. Gastroenterology 114: 50-57.
27. Gitlin N, McCullough AJ, Lacey Smith J et al (1987) A multicenter, double-blind, randomised, placebo-controlled comparison of nocturnal and twice-a-day famotidine in the treatment of active duodenal ulcer disease. Gastroenterology 92: 48-53.
28. Graham DY, Opekum A, Lew GM et al (1990) Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection. American Journal of Gastroenterology 85(4): 394-398.
29. Hamlet A & Olbe L (1996) The influence of Helicobacter pylori on postprandial duodenal acid load and duodenal bulb pH in humans. Gastroenterology 111: 391-400.
30. Haris AW, Gummett PA, Misiewicz JJ & Baron JH (1996) Eradication of Helicobacter pylori in patients with duodenal ulcer lowers basal and peak acid outputs to gastrin releasing peptide and pentagastrin. Gut 38: 663-667.
31. Harrison A, Isenberg JI, Schapira M & Hagie L (1982) Most patients with active symptomatic duodenal ulcers fail to develop ulcer-type pain in response to gastroduodenal acidification. Journal of Clinical Gastroenterology 4: 105-108.
32. Hirschowitz BI (1991) A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis. Gastroenterology 101: 1149-1158.
33. Hunt RH (1995) The relationship between the control of pH and healing and symptom relief in gastrooesophageal reflux disease. Alimentary Pharmacology and Therapeutics 9 (supplement 1): 3-7.
34. Joelsson B & Johnsson F (1989) Heartburn - the acid test. Gut 30: 1523-1525.
35. Joffe SN & Primrose JN (1983) Pain provocation test in peptic duodenitis. Gastrointestinal Endoscopy 29(4): 282-284.
36. Johnsen R, Bernersen B, Straume B et al (1991) Prevalences of endoscopic and histological findings in subjects with and without dyspepsia. British Medical Journal 302: 749-752.
37. Kang JY, Yap I, Guan R & Tay HH (1986) Acid perfusion of duodenal ulcer craters and ulcer pain: a controlled double blind study. Gut 27: 942-945.
38. Koop H, Willemer S, Steinbach F et al (1987) Influence of chronic drug-induced achlorhydria by substituted benzimidazoles on the endocrine stomach in rats. Gastroenterology 92: 406-413.
39. Lacey-Smith J, Opekun AR, Larkai E & Graham DY (1989) Sensitivity of oesophageal mucosa to pH in gastro-esophageal reflux disease. Gastroenterology 96: 683-689.
40. Lam SK, Isenberg JI, Grossman MI et al (1982) Rapid gastric emptying in duodenal ulcer patients. Digestive Diseases and Sciences 27: 598-604.
41. Lamers CBHW (1988) Hormonal regulation of gastric acid in peptic ulcer disease. Scandinavian Journal of Gastroenterology 23 (supplement 146): 5-10.
42. Lauritsen K, Aalykka C, Havelund T et al (1996) Effect of omeprazole in functional dyspepsia: a double-blind, randomised placebo-controlled study. Gastroenterology 110(4): A702.
43. Lee A, Dixon MF, Danon SJ et al (1995) Local acid production and Helicobacter pylori: a unifying hypothesis of gastroduodenal disease. European Journal of Gastroenterology and Hepatology 7: 461-465.
44. Levi S, Beardshall K, Haddad G et al (1989) Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet I: 1167-1168.
45. McColl KEL & Fullarton GF (1993) Duodenal ulcer pain - the role of acid and inflammation. Gut 34: 1300-1302.
46. McColl KEL, El-Omar EM, Gillen D (1997) Alterations in gastric physiology in Helicobacter pylori infection: causes of different diseases or all epiphenomena? Italian Journal of Gastroenterology and Hepatology 29: 459-464.
47. McColl KEL, El-Omar E, Gillen D et al (1998a) H. pylori induced hypergastrinaemia is related to bacterial CagA status. Gastroenterology (in press).
48. McColl KEL, El-Nujumi A, Murray LS et al (1998b) Assessment of symptomatic response as predictor of Helicobactor pylori status following eradication therapy in patients with ulcer. Gut 42: 618-622
49. McColl KEL, Fullarton GM, Chittajallu R et al (1991) Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects. Scandinavian Journal of Gastroenterology 26(3): 339-346.
50. McDonald AJ, Peden NR, Havton R et al (1980) Symptom relief and the placebo effect in the trial of an anti-peptic drug. Gut 21: 323-326.
51. Moss SF, Legon S, Bishop AE et al (1992) Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 340: 930-932.
52. Nyrén O, Adami H-O, Gustavsson S et al (1987) The 'epigastric distress syndrome'. Journal of Clinical Gastroenterology 9(3): 303-309.
53. Peterson WL, Sturdevant RAL, Frankl HD et al (1977) Healing of duodenal ulcer with an antacid regimen. New England Journal of Medicine 297(7): 341-345.
54. Queiroz DMM, Mendes EN, Rocha GA et al (1993) Effect of Helicobacter pylori eradication on antral gastrin- and somatostatin-immunoreactive cell density and gastrin and somatostatin concentrations. Scandinavian Journal of Gastroenterology 28: 858-864.
55. Shi G, Bruley des Varannes S, Scarpignato C et al (1995) Reflux related symptoms in patients with normal oesophageal exposure to acid. Gut 37: 457-464.
56. Smith A, Gillen D, Cochran K et al (1997) Ranitidine treatment induces dyspepsia in previously asymptomatic healthy volunteers. Gastroenterology 112(4): A293.
57. Squire BH, Glick S & Benn A (1968) Maximal acid output and oesophagitis in hiatus hernia. Thorax 23: 683-685.
58. Sumii M, Sumii K, Tari A et al (1994) Regulation of antral peptides by administration of omeprazole to healthy men. American Journal of Gastroenterology 89(11): 2033-2037.
59. Talley NJ (1991) Drag treatment of functional dyspepsia. Scandinavian Journal of Gastroenterology 26 (supplement 182): 47-60.
60. Talley NJ, Weaver AL, Tesmer DL & Zinsmeister AR (1993) Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology 105: 1378-1386.
61. Trimble KC, Pryde A & Heading RC (1995) Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD. Gut 37: 7-12.
62. Waldum HL, Amestad JS, Brenna E et al (1996) Marked increase in gastric acid secretory capacity after omeprazole treatment. Gut 29: 649-653.
63. 2 Receptor Antagonists, Gottingen, November 1977. Amsterdam: Excerpta Medica.